Journal of Psychiatric Research · Nov 2026
Ketogenic Metabolic Therapy Decreases the Allostatic Load in Severe Mental Illness
By Finlay S, Adegboye O, Rudd D et al.
Introduction Elevated allostatic load (AL), a cumulative measure of multisystem physiological dysregulations, is associated with increased morbidity and mortality and consistently observed in psychiatric disorders. Ketogenic metabolic therapy (KMT) may reduce physiological stress and, consequently, AL. This study examined the changes in AL in following a KMT intervention in individuals with schizophrenia (SCZ) and bipolar disorder (BD). Methods Twenty-one participants (16 BD, 5 SCZ) underwent a 16-week KMT intervention. AL was assessed at baseline and week 16, and adherence was monitored twice weekly through self-reported ketone measurements. Results Baseline AL was comparable between diagnostic groups. Across the full samples, AL significantly decreased over 16 weeks (7.29 to 6.14; p = 0.02; Hedges' g (g) = -0.52), with reductions in 13 participants (62%). Reductions were significant in BD (7.13 to 5.81; p=0.02; g=−0.60), but not SCZ (7.80 to 7.20; p=0.60; g=−0.23).: the between-group difference was not significant (p=0.26). The largest component-level improvements were in glucose and blood pressure, while LDL and ApoB increased. AL also decreased among fully adherent participants (n=14; p=0.01; g=−0.61), whereas the reduction among semi-adherent participants (n=6) was not significant. Conclusion KMT was associated with reduced AL, particularly among participants with BD and those fully adherent to the intervention. Findings are preliminary given the small sample, absence of a control group, and exploratory subgroup analyses. Larger controlled studies are needed.